Multiplexed Ion Beam Imaging (MIBI)
Multiplexed Ion Beam Imaging (MIBI™) technology enables high-definition spatial proteomics that uniquely provides actionable analysis of the tissue microenvironment, delivering novel insights into disease state, mechanism of action, and patient response.
Comprehensive spatial analysis of the tissue microenvironment
Cell
Classification
- Identify and enumerate cell populations
- Visualize the tissue microenvironment
Protein
Quantification
- Quantify expression of checkpoints and other key proteins with spatial context
Spatial
Analysis
- Analyze interactions between target and effector cells
- Map tumor-immune boundaries
High-definition spatial proteomics that can inform therapeutic selection
High-definition spatial proteomics that can inform therapeutic selection
Gain deeper understanding of the tumor microenvironment and reveal actionable insights. Identify responder populations or predict patient response.
Achieve quantitative single-cell phenotype mapping at subcellular resolution and identify key mechanisms of action with clinical grade repeatability.
MIBIscope™ System
Highly multiplexed tissue imaging and analysis.
- Robust instrumentation
- Rigorously validated reagents
- Easy-to-use visualization software
Spatial Proteomic Services
MIBI-enabled phenotype mapping and insight generation.
- Quantitative cell segmentation, classification, and spatial analysis
- Responder, non-responder cohort comparisons
- Results with clinical-grade reproducibility
See published data on MIBI-share
View
Publications
Publications
Read Our
MIBI Blog
MIBI Blog
Latest
News
News